创伤液体复苏:你需要知道什么
过去数十年严重创伤患者的复苏策略发生诸多变化。积极晶体液复苏因并发症发生率高及加重创伤诱导性凝血病而被基本放弃,重点转向用血浆或全血输血恢复凝血功能正常。黏弹性检测可识别高纤溶等创伤诱导性凝血病的致命后果,氨甲环酸治疗已被广泛研究。早期静脉补钙(甚至在输血前)的关键作用受到强调。纤维蛋白原浓缩物或冷沉淀、凝血酶原复合物等辅助措施正在研究中并被部分机构大量输血方案采纳。平衡成分输血(1:1:1或1:1:2)和全血已在北美创伤中心普及。
要点
- 积极晶体液复苏因并发症发生率高、加重创伤诱导性凝血病而基本被放弃。
- 重点转向用血浆或全血输血恢复凝血功能正常。
- 黏弹性检测可识别高纤溶等创伤诱导性凝血病的致命后果,氨甲环酸治疗已被广泛研究。
- 早期静脉补钙受强调,甚至在输血前即给予。
- 平衡成分输血(1:1:1或1:1:2)和全血已在北美创伤中心普及;纤维蛋白原浓缩物或冷沉淀、凝血酶原复合物正在研究中并被部分机构大量输血方案采纳。
适用人群与场景
- 严重创伤患者
处置流程与药物剂量
- 放弃积极晶体液复苏,因并发症发生率高并加重创伤诱导性凝血病。
- 用血浆或全血输血恢复凝血功能正常。
- 使用黏弹性检测识别高纤溶等创伤诱导性凝血病,并以氨甲环酸治疗。
- 早期静脉补钙,甚至在输血前给予。
- 平衡成分输血采用1:1:1或1:1:2比例;全血已在北美创伤中心普及。
- 纤维蛋白原浓缩物或冷沉淀补充纤维蛋白原、凝血酶原复合物正被研究并纳入部分机构大量输血方案。
红旗征与不能漏的情况
- 创伤诱导性凝血病的致命后果,如高纤溶。
研究设计与关键结果
- 综述描述创伤复苏的最新进展,并讨论近期创新与未来研究方向。
证据类型、等级与局限
- 证据类型:综述。
对床旁实践的改变
- 创伤复苏中不应以积极晶体液复苏为主,重点转向恢复凝血功能正常的输血策略。
- 可采用黏弹性检测识别高纤溶等创伤诱导性凝血病,并用氨甲环酸治疗。
- 强调早期静脉补钙,甚至在输血前给予。
- 平衡成分输血(1:1:1或1:1:2)和全血已在北美创伤中心普及。
- 纤维蛋白原浓缩物或冷沉淀、凝血酶原复合物正在研究中并被部分机构大量输血方案采纳。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
There have been numerous changes in resuscitation strategies for severely injured patients over the last several decades. Certain strategies, such as aggressive crystalloid resuscitation, have largely been abandoned because of the high incidence of complications and worsening of trauma-induced coagulopathy. Significant emphasis has been placed on restoring a normal coagulation profile with plasma or whole blood transfusion. In addition, the importance of the lethal consequences of trauma-induced coagulopathy, such as hyperfibrinolysis, has been easily recognized by the use of viscoelastic testing, and its treatment with tranexamic acid has been extensively studied. Furthermore, the critical role of early intravenous calcium administration, even before blood transfusion administration, has been emphasized. Other adjuncts, such as fibrinogen supplementation with fibrinogen concentrate or cryoprecipitate and prothrombin complex concentrate, are being studied and incorporated in some of the institutional massive transfusion protocols. Finally, balanced blood component transfusion (1:1:1 or 1:1:2) and whole blood have become commonplace in trauma centers in North America. This review provides a description of recent developments in resuscitation and a discussion of recent innovations and areas for future investigation.
参考来源
- Dhillon NK, Kwon J, Coimbra R, et al. Fluid resuscitation in trauma: What you need to know. J Trauma Acute Care Surg. 2024. PMID: 39213260. doi:10.1097/TA.0000000000004456
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。